New Delhi [India], December 30 (ANI): Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria on Wednesday said that India will have the COVID-19 vaccine within days.
New Delhi [India], December 31 (ANI): The government is aggressively working on the Covid-19 mass vaccination program and there will be no delay in the inoculation process, Dr Randeep Guleria, director All India Institute of Medical Sciences said on Wednesday. He also said that priority grou
New Delhi [India], December 31 (ANI): With India confirming at least 20 cases of the new UK strain of Covid-19, All India Institute of Medical Sciences director Randeep Guleria on Wednesday said that it is a possibility that the new mutation could have been present in the country even in
New Delhi [India], December 3 (ANI): Director of the All Indian Institute of Medical Sciences (AIIMS) Dr Randeep Guleria has said that he is hopeful of that by the end of this month or early next month, India will get emergency use authorisation for a coronavirus vaccine.
New Delhi [India], December 3 (ANI): Responding to vaccine impact during Chennai trial, Director of All India Institute of Medical Sciences (AIIMS) Dr Randeep Guleria on Thursday said the case, is an incidental finding rather than related to the vaccine candidate.
New Delhi [India], November 11 (ANI): Super-spreading events of COVID-19, in which big crowds with attendees do not take precautions leading to spread of infections on a large scale, must have occurred in Delhi, said All India Institute of Medical Sciences Delhi (AIIMS), Director, Dr Rand
New Delhi [India], November 11 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer's COVID-19 vaccine phase III trials are very encouraging but preserving it at very low temperatures, -70 degree C, will
New Delhi [India], October 22 (ANI): Even as the Indian Council of Medical Research announced that plasma therapy may soon be discontinued from the Covid-19 national treatment protocol, All India Institute of Medical Sciences (AIIMS) Delhi's Director Dr Randeep Guleria on Thursday said th
New Delhi [India], October 22 (ANI): Rising air pollution combined with coronavirus infection and lung complications can possibly lead to serious consequences, and therefore, higher mortality, Dr Randeep Guleria, Director of the All India Institute of Medical Sciences (AIIMS).
New Delhi [India], September 9 (ANI): All India Institute of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria has said that convalescent plasma therapy (CP) may be useful in early stages in a COVID-19 patient who is having a moderate disease and it should have sufficient antibod
New Delhi [India], Aug 11 (ANI): All India Institutes of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on Tuesday said that there was a need to assess the safety and effectiveness of COVID-19 vaccine developed by Russia if it is successful.
New Delhi [India], Aug 7 (ANI): Delhi Health Minister Satyendar Jain told mediapersons on Friday that when AIIMS Director Dr Randeep Guleria said that plasma therapy on COVID-19 patients did not show much clinical benefit in reducing fatality risk caused due to the virus, he did not mean